Skip to content
Partner desk
Partner desk

Concept company: no real medicines.

04Partners

Work with us at the stage that suits you.

Licensing, co-development, clinical batch filling, investor relations and questions from clinicians. Three desks, named people, one reply within five working days.

Write to a desk
  1. 01Business development
  2. 02Investors
  3. 03Clinicians

Specimen heads of termsBD-27-04 · draft 3

Co-development of OVT-319

1Asset
OVT-319, inflammatory skin disease
2Shape
Shared cost and shared decisions from the first human dose
3Territory
Worldwide, or split by region
4Governance
Joint steering committee, one vote each side
5Supply
Clinical batches filled in our own sterile plant

Payments fall at the gates

  1. Preclinical
  2. Phase 1
  3. Phase 2
  4. Phase 3

For Orvanthe

For the partner

Specimen · concept company

Business development

What we look for in a partner.

Write to this desk
  • A

    Out-licensing

    OVT-114 and OVT-207 from the end of their current studies, by territory or worldwide.

  • B

    Co-development

    OVT-319 in inflammatory skin disease, sharing cost and decisions from the first human dose.

  • C

    In-licensing

    Early programmes in fibrotic and metabolic disease where our assays add something.

  • D

    Batch filling

    Clinical-scale sterile fill and freeze drying, Grade A, for partners' own studies.

Investors

Results calendar.

Results are published on the day, in full, with the slides and a recorded call.

All dates are invented for this concept.

Write to this desk
  1. Feb 2027 12

    Full-year results

    Report, slides and a recorded call

  2. May 2027 14

    First-quarter update

    Short trading statement

  3. Sep 2027 23

    Research day

    Both sites, with the scientists who did the work

  4. Nov 2027 11

    Half-year results

    Report, slides and a recorded call

Clinicians

Questions about a study.

Our clinical team answers doctors and study nurses. We cannot give medical advice about an individual patient, and joining a study is always the patient's own decision, made with their own doctor.

Write to this desk

Write to a desk

Tell us which desk, and what you need.

Concept company: no real medicines.

Desk